From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families
22.9.2026 16:00:00 EEST | Business Wire | Press release
Colgate-Palmolive, the worldwide leader in oral care, announced a strategic evolution in its flagship oral health education program, Colgate Bright Smiles, Bright Futures® (BSBF), reflecting the Company’s commitment to global public health.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922129016/en/
Launched in 1991, the program has reached over two billion children and their families across more than 100 countries, demonstrating how private-sector commitment designed to support communities, can become a powerful force for public health, driving healthier behaviors and positive outcomes at scale. From health education curriculum and school programming to mobile dental vans and free oral health screenings, BSBF helps children and their families access care, adopt healthier habits, and improve long-term oral health outcomes.
“At Colgate-Palmolive, we believe oral health and healthier, brighter futures are inextricably linked,” said Noel Wallace, Chairman, President and Chief Executive Officer, Colgate-Palmolive. “For 35 years, BSBF has created positive impact by combining hands-on education with local partnerships that turn daily habits into healthy lifestyles. Our program is focused on helping more people build healthy habits for life.”
As BSBF is positioning itself to empower the next billion children and their families, the program’s evolution is guided by three core areas: a newly published impact report, human-centered design (HCD) & behavior change assets, and strategic global health partnerships.
Newly Published Impact Report
Authored by Dr. Francisco Ramos-Gomez and Dr. Yan Wang of University of California, Los Angeles (UCLA), Transforming Children's Oral Health Worldwide: Three Decades of the Colgate Bright Smiles, Bright Futures Prevention Program, synthesizes implementation data throughout the program’s global history. It demonstrates that combining curriculum-based lessons with supervised toothbrushing, fluoride varnish and sealants can deliver measurable results, including:
- A 75% reduction in new cavities and demineralized lesions on first permanent molars among children in Grenada.
- A 23% increase in healthy gingival units among children in Mexico City.
The evidence also highlights the power of role models, including teachers, nurses, community health workers, and sports coaches – in addition to dental professionals – and positions children as "change agents" who drive health habits across households.
“The body of evidence shows that BSBF's impact extends well beyond individual behavior change,” said Dr. Francisco Ramos-Gomez, Professor and Chair, Section of Pediatric Dentistry, UCLA School of Dentistry, and co-author of the report. “It strengthens non-dental workforce capacity, fosters public-private collaboration, and advances oral health equity at scale. BSBF offers a practical framework other global oral health initiatives can benefit from.”
Human-Centered Design (HCD) & Behavior Change Assets
To empower the next generation with lifelong healthy habits, BSBF has launched a new suite of health education resources that are core to its program, developed with Dalberg Design. Rooted in Human-Centered Design (HCD) and evidence-based behavior change principles, these tools were co-created and field-tested with children, caregivers, and educators across India, Kenya, Mexico, and the United States. By equipping teachers and families with culturally adapted learning tools and interactive brushing activities for children, BSBF continues to strengthen community-led health education and establish foundational oral hygiene habits in classrooms and homes worldwide.
Global Health Partnerships
Announced earlier this year at Davos during the World Economic Forum, a multi-year funding commitment to the WHO Foundation supports the World Health Organization’s global oral health program. The collaboration focuses on expanding oral health education, supporting integration of oral health into national health systems, and raising awareness of oral health as a public health priority. “Oral health plays an essential role in overall health,” said Anil Soni, Chief Executive Officer of the WHO Foundation. “Progress depends on long-term investment in prevention, trusted guidance, and strong health systems. Support like this helps enable WHO’s work to advance oral health and improve health outcomes for communities around the world.”
Building on 35 years of measurable behavioral and clinical success, the program is entering its next phase of growth – driving impact by reaching the next billion children and families while inspiring new approaches to tackling global health challenges. On September 22, alongside the 81st United Nations General Assembly, Colgate-Palmolive will convene business, global health experts, and civil society leaders for an expert discussion to examine how evidence, behavior change and cross-sector collaboration can drive sustained health outcomes. Hosted by Noel Wallace, Chairman, President and Chief Executive Officer, and Esha Gupta, Global Head of Public Health and Social Impact, Colgate-Palmolive, the conversation, moderated by Moira Forbes, Executive Vice President, Forbes, will feature an expert discussion with Robert Fabricant, Co-Founder and Partner, Dalberg Design; Dr. Saia Ma’u Piukala, WHO Regional Director for the Western Pacific; Janti Soeripto, CEO and President, Save the Children US; and Anil Soni, CEO, WHO Foundation.
About Colgate-Palmolive
Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, Ajax, Axion, Darlie, elmex, EltaMD, Fabuloso, Filorga, hello, Hill’s Prescription Diet, Hill’s Science Diet, Irish Spring, Lady Speed Stick, meridol, PCA SKIN, Prime100, Protex, Sanex, Softsoap, Sorriso, Soupline, Speed Stick, Suavitel and Tom’s of Maine. We are recognized for our leadership and innovation in promoting sustainability and community wellbeing, including our achievements in decreasing plastic waste and promoting recyclability, saving water and improving children’s oral health through our Colgate Bright Smiles, Bright Futures program, which has reached over two billion children and their families since 1991. For more information about Colgate-Palmolive and how we make more smiles, visit www.colgatepalmolive.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260922129016/en/
Contacts
Media Contact
Campbell O’Connor
Real Chemistry
203-993-5551
coconnor@realchemistry.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 16:30:00 EEST | Press release
Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be shared at the congress. “Takeda’s data at ESMO reflect our commitment to delivering rapid progress for patients living with some of the most prevalent and challenging cancers, including advanced gastric cancer and immunotherapy-resistant and previously untreated non-small cell lung cancer,” said Phuong Khanh (P.K.) Morrow, M.D., Head of the Oncology Therapeutic Area Unit at Takeda. “Our mission is to advance new therapeutic approaches for patients who need more options or who remain underserved by cur
Quaise Energy Selected for Up to $25 Million in U.S. Department of Energy Support to Advance World's First Commercial Superhot Geothermal Power Plant22.9.2026 16:30:00 EEST | Press release
Quaise Energy, a leading developer of utility-scale superhot geothermal energy, today announced that it has been selected by the U.S. Department of Energy (DOE) for up to $25 million in funding under the Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and Confirmation funding opportunity. The support brings the U.S. closer to commercializing superhot Enhanced Geothermal Systems — technology that could unlock firm, clean power from hot rock beneath virtually any geography in the country. The funding will advance Project Obsidian, the world's first commercial superhot geothermal power plant, in Central Oregon. It will support analysis of the drilling, stimulation, and flow results of the first two wells to optimize a third well at the Obsidian site. The three-well configuration is targeting average reservoir temperatures of over 300°C and is designed to demonstrate more than 25 megawatts of gross electric power capacity. The DOE funding will also enable Qu
Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio22.9.2026 15:30:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that data from across its Inflammation and Autoimmunity (IAI) portfolio will be presented at the European Academy of Dermatology and Venereology (EADV) 2026, held September 30 - October 3, 2026, in Vienna, Austria. "The breadth of research being presented at EADV 2026 highlights the strength of our Inflammation and Autoimmunity portfolio," said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "Data presentations in hidradenitis suppurativa, atopic dermatitis and prurigo nodularis demonstrate our commitment to advancing innovation across immune-mediated skin diseases and deepening our understanding of the patient experience." Details on key Incyte data presentations at EADV include: Oral Presentations Atopic Dermatitis Atopic Dermatitis and Life Course Disruption: Evidence From a Multidimensional International Survey (TOPiQAL) (Session: Free Communication 1: Atopic dermatitis/Eczema. Thursday, October 1, 2:50-3:0
Citi Wealth’s 2026 Global Family Office Report Reveals Clients Are Shifting Their Focus Towards Public Equities While Becoming More Deliberate and Resilient Amid Uncertainty22.9.2026 15:30:00 EEST | Press release
Citi Wealth today released its 2026 Global Family Office Report, offering an inside perspective into the thinking and behaviors of the world’s most sophisticated investors. The report was compiled by Citi Wealth’s Global Family Office Group, which works with more than 1,900 family offices worldwide. Conducted in June and July 2026, the survey sheds light on how over 350 family offices in more than 40 countries are navigating new complexities in an era defined by uncertainty. Today’s leading family offices are building long-term strategies underpinned by three key themes: capital, capability and continuity. They are investing with confidence -- becoming more institutional in how they invest, more sophisticated in how they manage risk, and more intentional in how they prepare for the future. Families also are prioritizing leadership succession and generational transition with new urgency. Key takeaways include: Strong Performance in the Face of Rising Uncertainty: Despite shifting macroe
Manhattan Associates Announces Editions™ for its Industry-Leading Solutions, Making Them Accessible at Every Stage of Growth22.9.2026 15:30:00 EEST | Press release
Manhattan Associates (NASDAQ: MANH), the global leader in supply chain commerce with unmatched AI capabilities, today announced the commercial launch of Editions for Manhattan Active® solutions. Editions provide a new way for companies of all sizes and across industries to partner with Manhattan. They are designed to help growing organizations make a durable, long-term technology decision from the start. As complexity increases, customers can unlock additional capabilities on the same platform, rather than starting over. Built for ActiveWarehouse™, ActiveTransportation™, ActiveStore™ and ActiveOrder™, on Manhattan’s award-winning ActivePlatform™, there are three Editions available: Essentials, Enterprise and Enterprise Premier. Regardless of the Edition selected for each solution, companies gain access to the power of a unified platform, AI capabilities and continuous innovation that underpin some of the world’s most complex supply chain and commerce operations. Editions are not separa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom